Clinical Trial Update: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial studying ibutamoren for nonalcoholic fatty liver disease has completed and posted results. The study was sponsored by Massachusetts General Hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Ibutamoren (ibutamoren)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: NAFLD, Nonalcoholic Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2026-01-06